Figure 1From: Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapyThe presence of Sox9, Sox10 and Slug in tumor and stroma was compared before and after treatment in our collectiv of breast cancer patients. They are grouped in 4 categories of marker expression, to be specific: no expression = 0,low expression = 1+, moderate expression = 2+, high expression = 3+.Back to article page